Clarke RB - Search Results

1

Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.

Giordano C, Chemi F, Panza S, Barone I, Bonofiglio D, Lanzino M, Cordella A, Campana A, Hashim A, Rizza P, Leggio A, Győrffy B, Simões BM, Clarke RB, Weisz A, Catalano S, Andò S. Giordano C, et al. Among authors: clarke rb. Oncotarget. 2016 Jan 12;7(2):1262-75. doi: 10.18632/oncotarget.6014. Oncotarget. 2016. PMID: 26556856 Free PMC article.

2

Breast stem cells and cancer.

Farnie G, Clarke RB. Farnie G, et al. Among authors: clarke rb. Ernst Schering Found Symp Proc. 2006;(5):141-53. doi: 10.1007/2789_2007_049. Ernst Schering Found Symp Proc. 2006. PMID: 17939300 Review.

3

Resistance to endocrine therapy: are breast cancer stem cells the culprits?

O'Brien CS, Howell SJ, Farnie G, Clarke RB. O'Brien CS, et al. Among authors: clarke rb. J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):45-54. doi: 10.1007/s10911-009-9115-y. Epub 2009 Feb 28. J Mammary Gland Biol Neoplasia. 2009. PMID: 19252972 Review.

4

Breast cancer stem cells: something out of notching?

Harrison H, Farnie G, Brennan KR, Clarke RB. Harrison H, et al. Among authors: clarke rb. Cancer Res. 2010 Nov 15;70(22):8973-6. doi: 10.1158/0008-5472.CAN-10-1559. Epub 2010 Nov 2. Cancer Res. 2010. PMID: 21045140 Review.

5

Breast cancer stem cells and their role in resistance to endocrine therapy.

O'Brien CS, Farnie G, Howell SJ, Clarke RB. O'Brien CS, et al. Among authors: clarke rb. Horm Cancer. 2011 Apr;2(2):91-103. doi: 10.1007/s12672-011-0066-6. Horm Cancer. 2011. PMID: 21761332 Free PMC article. Review.

6

A detailed mammosphere assay protocol for the quantification of breast stem cell activity.

Shaw FL, Harrison H, Spence K, Ablett MP, Simões BM, Farnie G, Clarke RB. Shaw FL, et al. Among authors: clarke rb. J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):111-7. doi: 10.1007/s10911-012-9255-3. Epub 2012 Jun 5. J Mammary Gland Biol Neoplasia. 2012. PMID: 22665270 Review.

7

Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.

Singh JK, Farnie G, Bundred NJ, Simões BM, Shergill A, Landberg G, Howell SJ, Clarke RB. Singh JK, et al. Among authors: clarke rb. Clin Cancer Res. 2013 Feb 1;19(3):643-56. doi: 10.1158/1078-0432.CCR-12-1063. Epub 2012 Nov 13. Clin Cancer Res. 2013. PMID: 23149820 Free PMC article.

8

Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.

Harrison H, Rogerson L, Gregson HJ, Brennan KR, Clarke RB, Landberg G. Harrison H, et al. Among authors: clarke rb. Cancer Res. 2013 Feb 15;73(4):1420-33. doi: 10.1158/0008-5472.CAN-12-2505. Epub 2012 Dec 17. Cancer Res. 2013. PMID: 23248117

9

Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.

Harrison H, Simões BM, Rogerson L, Howell SJ, Landberg G, Clarke RB. Harrison H, et al. Among authors: clarke rb. Breast Cancer Res. 2013 Mar 8;15(2):R21. doi: 10.1186/bcr3396. Breast Cancer Res. 2013. PMID: 23497505 Free PMC article.

10

Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity.

Lamb R, Lehn S, Rogerson L, Clarke RB, Landberg G. Lamb R, et al. Among authors: clarke rb. Cell Cycle. 2013 Aug 1;12(15):2384-94. doi: 10.4161/cc.25403. Epub 2013 Jun 26. Cell Cycle. 2013. PMID: 23839043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page